Journal AAPS Journal

Correction: Prediction of Individual Disease Progression Including Parameter Uncertainty in Rare Neurodegenerative Diseases: The Example of Autosomal-Recessive Spastic Ataxia Charlevoix Saguenay (ARSACS)

N Hendrickx , F Mentré , A Traschütz , ... , E Comets

10.1208/s12248-024-00932-8

Machine-Learning Assisted Screening of Correlated Covariates: Application to Clinical Data of Desipramine

IG Asiimwe , B S'fiso Ndzamba , S Mouksassi , ... , J Lang

10.1208/s12248-024-00934-6

Correction: Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models-a New Method Based on Metropolis-Hastings Algorithm.

M Guhl , J Bertrand , L Fayette , ... , E Comets

10.1208/s12248-024-00933-7

Simulating Healthy Participant Pharmacokinetics for Renal and Hepatic Impairment Studies: Retrospective Assessment of the Approach.

JP Prybylski , Y Wang , V Sahasrabudhe , V Purohit

10.1208/s12248-024-00928-4

Playing Hide-and-Seek with Tyrosine Kinase Inhibitors: Can We Overcome Administration Challenges?

S Kollipara , M Chougule , R Boddu , ... , T Ahmed

10.1208/s12248-024-00939-1

Pioneering Topical Ointment Intervention for Unprecedented Antimicrobial and Diabetic Wound Management with Phenylpropanoids and Nano-Silver

HP Nagaiah , PD Periyakaruppan Murugesan , CV Ravindra Rupali , KP Shunmugiah

10.1208/s12248-024-00936-4

Design of Crosslinking Antibodies For T-Cell Activation: Experimental and Computational Analysis of PD-1/CD137 Bispecific Agents

A Kopp , J Guan , C Johnston , ... , GM Thurber

10.1208/s12248-024-00937-3

Physiologically Based Biopharmaceutics Modeling for Gefapixant IR Formulation Development and Defining the Bioequivalence Dissolution Safe Space

M Wang , T Heimbach , W Zhu , ... , F Kesisoglou

10.1208/s12248-024-00938-2

3-CMC, 4-CMC, and 4-BMC Human Metabolic Profiling: New Major Pathways to Document Consumption of Methcathinone Analogues?

D Berardinelli , O Taoussi , G Daziani , ... , J Carlier

10.1208/s12248-024-00940-8

Doses Evaluated in Clinical Pharmacology Studies Investigating the Effect of Intrinsic and Extrinsic Factors on PK and Safety: Case Examples from Approved Drug Development Programs

R Kaspera , Y Shitara

10.1208/s12248-024-00935-5